Marken rolls out GPS tracking on key shipments
August 25, 2015
Clinical logistics organisation Marken is rolling out GPS tracking for key shipments as it aims to improve real-time track-and-trace capability.
North Carolina-based Marken will offer clients a continuous, shipment-specific device, which will track the location of each shipment in real time. In addition to reporting its location, the device will report its temperature, motion and shock, light exposure (open box), atmospheric pressure and remaining battery life.
The company will also offer geo-fencing at all airports and can customise geo-fence waypoints and status updates for each validated shipping lane. The device transmits in real time and communicates through customised cloud-based software.
The GPS devices and custom-designed software come from Texas company OnAsset Intelligence. The device and software are protected by over 15 patents and are approved for use on more than 40 airlines.
“We are very excited to be working with Marken,” said Adam Crossno, OnAsset Intelligence chief executive officer. “OnAsset’s Sentry FlightSafe devices, Vision platform and real-time tracking and monitoring across all modes of transport combined with Marken’s industry-leading services and Maestro software are a powerful solution that is unmatched in the marketplace. Being part of the Marken team that is providing a holistic suite of services that offers compliance with global regulations, security and real-time validation for such important shipments is game changing. We look forward to showing the world the combined power of real-time technology and logistics service excellence.”
Marken made the decision to take this step to demonstrate the company’s commitment to high value clinical trial drug substance and drug products, which are increasingly derived from sensitive biologic material.
“Marken believes that by offering this state-of-the-art tracking device, we have taken an important and necessary step which guarantees the safe delivery of each drug shipment,” said Marken’s chief executive officer Wes Wheeler. “Marken is committed to providing the latest technology available, and we believe we have found it with OnAsset. Our agreement with OnAsset also comes at an important time in our industry, where GDP compliance is becoming a mandate in our industry. It also allows us to comply with recent updates to Annex 15 in Europe.”
Marken is dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. It integrates depot and logistics that extend the reach of clinical trials to remote treatment-naive geographies.
OnAsset Intelligence makes wireless devices that monitor all modes of transport including land, sea and air.